Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BOSTON SCIENTIFIC CORP Director's Dealing 2020

Oct 5, 2020

29821_dirs_2020-10-05_dc3d8b16-cc53-4b9d-ae6f-2805542758ce.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2020-10-01

Reporting Person: MACMILLAN STEPHEN P (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-10-01 Common Stock A 498.0000 $0.0000 Acquired 8000.0000 Direct

Footnotes

F1: Restricted stock granted in lieu of cash compensation, vesting in full upon the next annual meeting of stockholders. Reflects a value of $19,167, divided by the closing price of common stock on the date of grant. This grant represents the equivalent of two months of the board cash retainer as a result of board approval of the restoration of a portion of its cash compensation as disclosed on a Form 8-K dated October 5, 2020.